Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Arvinas Inc (NASDAQ: ARVN) closed at $33.45 up 0.03% from its previous closing price of $33.44. In other words, the price has increased by $0.03 from its previous closing price. On the day, 0.52 million shares were traded. ARVN stock price reached its highest trading level at $33.9058 during the session, while it also had its lowest trading level at $32.8.
Ratios:
For a deeper understanding of Arvinas Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.98 and its Current Ratio is at 4.98. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on February 28, 2024, Reiterated its Outperform rating but revised its target price to $80 from $95 previously.
On February 14, 2024, Citigroup Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $36 to $55.
On February 01, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $70.Goldman initiated its Buy rating on February 01, 2024, with a $70 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 23 ’24 when Houston John G sold 5,196 shares for $47.05 per share. The transaction valued at 244,472 led to the insider holds 1,036,681 shares of the business.
Cassidy Sean A sold 1,702 shares of ARVN for $80,079 on Feb 23 ’24. The Chief Financial Officer now owns 181,916 shares after completing the transaction at $47.05 per share. On Feb 23 ’24, another insider, Taylor Ian, who serves as the Chief Scientific Officer of the company, sold 1,701 shares for $47.05 each. As a result, the insider received 80,032 and left with 147,522 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARVN now has a Market Capitalization of 2284915968 and an Enterprise Value of 1019607360. For the stock, the TTM Price-to-Sale (P/S) ratio is 29.01 while its Price-to-Book (P/B) ratio in mrq is 3.45. Its current Enterprise Value per Revenue stands at 12.989 whereas that against EBITDA is -2.57.
Stock Price History:
Over the past 52 weeks, ARVN has reached a high of $53.08, while it has fallen to a 52-week low of $13.57. The 50-Day Moving Average of the stock is -24.28%, while the 200-Day Moving Average is calculated to be 8.68%.
Shares Statistics:
For the past three months, ARVN has traded an average of 743.97K shares per day and 594210 over the past ten days. A total of 68.00M shares are outstanding, with a floating share count of 58.38M. Insiders hold about 14.26% of the company’s shares, while institutions hold 89.50% stake in the company. Shares short for ARVN as of 1711584000 were 8600168 with a Short Ratio of 11.56, compared to 1709164800 on 8354713. Therefore, it implies a Short% of Shares Outstanding of 8600168 and a Short% of Float of 14.09.
Earnings Estimates
Currently, Trevena, Inc. analysts are dedicated to thoroughly evaluating and rating the performance of Arvinas Inc (ARVN) in the stock market.The consensus estimate for the next quarter is $3.68, with high estimates of $14.57 and low estimates of $33.45.
Analysts are recommending an EPS of between $Consumer Cyclical and $Healthcare for the fiscal current year, implying an average EPS of $Basic Materials.
